Los Angeles Capital Management & Equity Research Inc. trimmed its holdings in shares of HealthSouth Corporation (NYSE:HLS) by 19.2% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 127,890 shares of the company’s stock after selling 30,435 shares during the period. Los Angeles Capital Management & Equity Research Inc. owned 0.13% of HealthSouth Corporation worth $6,190,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. First Mercantile Trust Co. raised its holdings in shares of HealthSouth Corporation by 18.8% during the second quarter. First Mercantile Trust Co. now owns 2,720 shares of the company’s stock worth $132,000 after purchasing an additional 430 shares during the period. Neuburgh Advisers LLC raised its holdings in shares of HealthSouth Corporation by 40.1% during the first quarter. Neuburgh Advisers LLC now owns 3,072 shares of the company’s stock worth $132,000 after purchasing an additional 880 shares during the period. Glen Harbor Capital Management LLC raised its holdings in shares of HealthSouth Corporation by 40.1% during the first quarter. Glen Harbor Capital Management LLC now owns 4,224 shares of the company’s stock worth $181,000 after purchasing an additional 1,210 shares during the period. HL Financial Services LLC acquired a new stake in shares of HealthSouth Corporation during the second quarter worth $213,000. Finally, BB&T Corp acquired a new stake in shares of HealthSouth Corporation during the first quarter worth $200,000. 93.10% of the stock is currently owned by institutional investors.

Shares of HealthSouth Corporation (NYSE:HLS) opened at 45.42 on Tuesday. The firm has a market cap of $4.48 billion, a PE ratio of 16.55 and a beta of 0.59. The company has a 50 day moving average of $44.05 and a 200-day moving average of $44.85. HealthSouth Corporation has a 12-month low of $36.97 and a 12-month high of $49.71.

HealthSouth Corporation (NYSE:HLS) last issued its earnings results on Monday, July 31st. The company reported $0.71 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.68 by $0.03. HealthSouth Corporation had a net margin of 6.70% and a return on equity of 25.07%. The company had revenue of $981.30 million for the quarter, compared to the consensus estimate of $976.46 million. During the same quarter in the previous year, the company earned $0.69 EPS. The firm’s revenue for the quarter was up 6.6% compared to the same quarter last year. Equities research analysts forecast that HealthSouth Corporation will post $2.71 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Monday, October 2nd will be paid a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 2.20%. The ex-dividend date of this dividend is Friday, September 29th. This is an increase from HealthSouth Corporation’s previous quarterly dividend of $0.24. HealthSouth Corporation’s payout ratio is currently 35.29%.

In other news, CEO Mark J. Tarr sold 22,625 shares of the business’s stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $42.55, for a total value of $962,693.75. Following the sale, the chief executive officer now owns 283,134 shares in the company, valued at approximately $12,047,351.70. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.60% of the stock is currently owned by insiders.

A number of brokerages have weighed in on HLS. KeyCorp reissued a “hold” rating on shares of HealthSouth Corporation in a report on Thursday, September 7th. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $55.00 price objective on shares of HealthSouth Corporation in a report on Wednesday, September 6th. ValuEngine cut shares of HealthSouth Corporation from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Stephens began coverage on shares of HealthSouth Corporation in a report on Thursday, August 31st. They issued an “overweight” rating and a $53.00 price objective on the stock. Finally, Zacks Investment Research cut shares of HealthSouth Corporation from a “buy” rating to a “hold” rating in a report on Tuesday, August 15th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and three have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $49.71.

ILLEGAL ACTIVITY WARNING: This news story was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another site, it was illegally stolen and reposted in violation of US and international trademark & copyright law. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/09/12/los-angeles-capital-management-equity-research-inc-reduces-holdings-in-healthsouth-corporation-hls.html.

HealthSouth Corporation Profile

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corporation (NYSE:HLS).

Institutional Ownership by Quarter for HealthSouth Corporation (NYSE:HLS)

Receive News & Stock Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related stocks with our FREE daily email newsletter.